More on GRAL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (4.4 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GRAIL, Inc. (NQ:GRAL)
Delayed: 79.79 +0.42 (0.53%)
Prev. Close $79.37  
Open$79.00 
52 Wk High$ 
52 Wk Low$ 
Day High$80.79 
Day Low$77.74 
P/E N/A  
EPS$ 
Volume467,186 

Friends, Peers and Foes (?): GRAL.V, WGS, BMI, VRRM, PACB (more...)

Aug 27, 2026 04:26 PM Form 144 GRAIL, Inc. Filed by: Ofman Joshua J.
Aug 27, 2026 04:19 PM Form 144 GRAIL, Inc. Filed by: Freidin Aaron
Aug 13, 2026 05:15 PM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 7, 2026 11:05 AM FDA panel set to review GRAIL's multi-cancer blood test application
Aug 7, 2026 11:05 AM GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
Aug 7, 2026 09:44 AM Form SCHEDULE 13G GRAIL, Inc. Filed by: STATE STREET CORP
Aug 6, 2026 05:02 PM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: PRIMECAP MANAGEMENT CO/CA/
Aug 6, 2026 04:17 PM Form 10-Q GRAIL, Inc. For: Jun 30
Aug 5, 2026 04:15 PM GRAIL, Inc. (GRAL) Reports Q2 Loss of $2.56
Aug 5, 2026 04:12 PM Form 8-K GRAIL, Inc. For: Aug 05
View All Articles

Entities mentioned with GRAL

View All Entities